The importance of the liver in mediating the anti-obesity action of glucagon administration is exemplified by findings in liver-specific knockout models, where the absence of the GCGR ablates the ability of glucagon to induce weight loss (54, 81). Here, GCG is linked to obesity due to melanocortin 4 receptor deficiency.